Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl
24 Juin 2024 - 1:00PM
Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family
building, and women’s health benefits solution, today announced an
expansion of its global offering with the acquisition of Apryl, a
Berlin-based fertility benefits platform founded in 2019. This
acquisition enhances Progyny’s guided, concierge support that
enables employees around the world to navigate the complexities of
fertility and family building care.
Progyny’s global benefits solution supports multinational
employers and their employee populations in over 100 countries.
Progyny’s services allow employers the flexibility to offer
fertility and family building benefits that comply with the
intricacies of country-specific laws and regulations as it relates
to fertility and family building services, treatments, and benefit
design.
“Employers recognize the importance of providing fertility and
family building benefits and want to be able to streamline these
efforts to ensure their employees have equitable benefits and
consistent high-touch experiences, regardless of where they live,”
said Pete Anevski, CEO of Progyny. “We’re excited to broaden our
support on a global scale.”
Progyny’s enhanced global services include:
- Holistic support across
preconception, fertility, fertility treatments, adoption, and
surrogacy
- A streamlined patient experience
with personalized concierge support
- Access to thousands of vetted
fertility clinics
- Secure financial processing in the
member’s local currency
- A seamless benefit integration and
implementation with ability to customize by country
- Secure and GDPR compliant platform,
which safeguards employee data and provides stringent fraud
detection, ensuring services and claims meet local regulations and
laws
Jenny Saft, co-founder of Apryl, said, “We saw the incredible
solution and impact Progyny had created in the U.S. and founded
Apryl with the vision of achieving this success globally. The Apryl
team is thrilled to join Progyny to bring employers and their
employees around the world access to best-in-class benefits that
make dreams of family come true.”
For more information about Progyny visit www.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family
building and women’s health benefits solution, trusted by the
nation’s leading employers, health plans and benefit purchasers. We
envision a world where everyone can realize their dreams of family
and ideal health. Our outcomes prove that comprehensive, inclusive,
and intentionally designed solutions simultaneously benefit
employers, patients and physicians.
Our benefits solution empowers patients with concierge support,
coaching, education, and digital tools; provides access to a
premier network of fertility and women's health specialists who use
the latest science and technologies; drives optimal clinical
outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for
its leadership and growth as a TIME100 Most Influential Company,
CNBC Disruptor 50, Modern Healthcare's Best Places to Work in
Healthcare, Forbes' Best Employers, Financial Times Fastest Growing
Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for
NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:James Hartinvestors@progyny.com
Media:Selena Yangmedia@progyny.com
Progyny (NASDAQ:PGNY)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Progyny (NASDAQ:PGNY)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025